Skip to main content
. 2020 Aug;8(16):1007. doi: 10.21037/atm-20-5332

Figure 3.

Figure 3

SNHG22/miR-429 /SESN3 axis was proved in ESCC cells. (A) Venn diagram was drawn to show potential mRNAs. (B) qRT-PCR assay was implemented to search which mRNA was highly expressed in TE-10 and Eca109 cells and could be affected by SNHG22 and miR-429. (C) SESN3 expression was evaluated in the human esophageal epithelial cell (HET-1A) and esophageal squamous cell carcinoma cells (Kyse-150, TE-10, and Eca109) via the qRT-PCR assay. (D) The binding site of SESN3 and miR-429 was presented according to ENCORI. (E) Luciferase reporter assay was conducted to verify the binding relationship in SESN3 and miR-429. (F) RIP assay was used to prove the binding of SNHG22, miR-429, and SESN3. **, P<0.01. SNHG22, small nucleolar RNA host gene 22; ESCC, esophageal squamous cell carcinoma; qRT-PCR, quantitative real-time PCR.